Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: GC Corp.

Market Cap 488B 319M 278M 257M 241M 451M 30.08B 455M 3.06B 1.18B 14.81B 1.2B 1.17B 51.57B P/E 2024
33.4x
P/E 2025 -10.4x
Enterprise Value 1,882B 1.23B 1.07B 992M 930M 1.74B 116B 1.76B 11.79B 4.57B 57.11B 4.62B 4.52B 199B EV / Sales 2024
0.83x
EV / Sales 2025 0.86x
Free-Float
44.46%
Yield 2024
2.89%
Yield 2025 -
06-10 GC Corp.(KOSE:A005250) dropped from KOSPI 200 Index CI
05-27 Green Cross Holdings to divest 460 billion won worth of stake in Curevo RE
05-15 GC Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-30 Green Cross Holdings Corporation acquired 22.08% stake in GREEN CROSS WellBeing Corporation from GC Biopharma Corp. for KRW 50.5 billion. CI
03-18 GC Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02-10 Green Cross Holdings Corporation announces Annual dividend, payable on April 17, 2026 CI
11-14 Green Cross Holdings Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-08-14 Green Cross Holdings Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-06-18 Green Cross Holdings Corporation agreed to acquire an additional 23.56% stake in GC Care for KRW 71.9 billion. CI
25-05-15 Green Cross Holdings Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-03-18 Green Cross Holdings Corporation Reports Earnings Results for the Full Year Ended December 31, 2024 CI
24-11-14 Green Cross Holdings Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
24-11-05 China Resources Boya Bio-pharmaceutical Group Co.,Ltd completed the acquisition of 100% stake in Green Cross Hk Holdings Limited from Green Cross Holdings Corporation, Synaptic 1st Private Equity Fund and others for CNY 1.82 billion. CI
1 day-4.89%
1 week-0.09%
Current month-17.18%
1 month-31.67%
3 months-22.35%
6 months-36.80%
Current year-32.79%
1 week 10,520
Extreme 10520
12,000
1 month 9,580
Extreme 9580
15,770
Current year 9,580
Extreme 9580
18,010
1 year 9,580
Extreme 9580
18,010
3 years 9,580
Extreme 9580
18,490
5 years 9,580
Extreme 9580
36,550
10 years 9,580
Extreme 9580
56,300
Manager TitleAgeSince
Chief Executive Officer 52 2010-02-28
Chief Executive Officer 72 2010-03-24
Director of Finance/CFO 53 -
Director TitleAgeSince
Chairman 72 2010-12-16
Director/Board Member 76 2009-02-28
Director/Board Member 52 2010-02-28
Date Insider Type Main position Quantity % Market Cap.
25-04-24Buy

Chief Executive Officer

15,000 0.0319%
25-04-24Buy

Chief Executive Officer

752 0.0016%
25-04-24Buy

Chief Executive Officer

1,334 0.0028%
Change 5-day change 1-year change 3-year change Capi.($)
-4.89%-0.09%-34.56%-26.81% 319M
-1.21%-3.04%+39.94%+145.38% 980B
-2.48%-5.18%+51.52%+39.07% 550B
-2.14%-4.94%+16.71%+56.15% 382B
+0.25%-3.09%+23.00%+15.81% 316B
+0.61%-1.69%+25.42%+13.64% 272B
+0.22%-3.10%+24.25%+30.21% 268B
+4.59%+1.98%-40.02%-45.89% 199B
-1.19%-4.95%+16.56%+47.00% 182B
-1.35%-1.46%+14.59%+56.94% 154B
Average -0.76%-2.96%+13.74%+33.15% 330.27B
Weighted average by Cap. -0.78%-3.68%+27.79%+63.69%

Financials

2024 2025
Net sales 2,205B 1.44B 1.26B 1.16B 1.09B 2.04B 136B 2.06B 13.82B 5.35B 66.91B 5.41B 5.29B 233B 2,451B 1.6B 1.4B 1.29B 1.21B 2.27B 151B 2.29B 15.36B 5.95B 74.4B 6.01B 5.89B 259B
Net income 24.03B 15.71M 13.69M 12.66M 11.87M 22.22M 1.48B 22.42M 151M 58.28M 729M 58.93M 57.68M 2.54B -69.51B -45.46M -39.62M -36.63M -34.34M -64.3M -4.29B -64.86M -436M -169M -2.11B -171M -167M -7.35B
Net Debt 1,042B 681M 594M 549M 515M 964M 64.24B 972M 6.53B 2.53B 31.62B 2.56B 2.5B 110B 1,394B 912M 795M 735M 689M 1.29B 85.93B 1.3B 8.74B 3.38B 42.31B 3.42B 3.35B 147B
Logo GC Corp.
Green Cross Holdings is a Korea-based holding company principally engaged in the manufacture and distribution of pharmaceuticals. The Company operates its business through five segments. The Pharmaceutical Manufacturing and Sale segment mainly manufactures and sells blood products, general pharmaceuticals, vaccines and over-the-counter (OTC) drugs. The Medical Service and System Development and Supply segment primarily provides healthcare services. The Diagnostic and Analysis segment mainly engages in blood diagnostics and genetic analysis business. The Leasing and Service Business segment is primarily involved in the real estate leasing and the management of affiliated group companies. The Other segment mainly operates livestock operation and other business.
Employees
144
Date Price Change Volume
26-06-19 10,700.00 -4.89% 178,869
26-06-18 11,250.00 -4.09% 168,077
26-06-17 11,730.00 +0.43% 110,759
26-06-16 11,680.00 +6.47% 244,172
26-06-15 10,970.00 +2.43% 167,512
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. A005250 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!